ZME Science on MSN
FDA Approves First New Gonorrhea Treatments In 30 Years
This month, the U.S. Food and Drug Administration cleared two new oral antibiotics for use against gonorrhea: zoliflodacin ...
FDA approves Johnson & Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma treatment.
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
Las Vegas, NV / / December 24, 2025 / ContrastConnect Key Takeaways CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast ...
Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...
Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
An experimental pain-relieving drug delivery method for farm animals using biodegradable microneedle patches was conducted by researchers with the Arkansas Agricultural Experiment Station to alleviate ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
H.R. 875 – Jeremy and Angel Seay and Sergeant Brandon Mendoza Protect Our Communities from DUIs Act of 2025 (June 24, 2025) H.R. 275 – Special Interest Alien Reporting Act of 2025 (June 24, 2025) S.J.
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results